Faux Xanax: Counterfeit drugs and your patients
Yes, dental professionals should be concerned about their patients taking counterfeit drugs. In this episode of Medical History Mysteries, we’ll look at the example of three recent hospitalizations triggered by counterfeit Xanax to illustrate why it's important to ask your patients the right questions, even if they're awkward. Doing so can prevent an emergency in your chair or other adverse outcomes. Find out why in this video.
Thumbnail background image credit: Photo 99799277 © Pureradiancephoto | Dreamstime.com
More Medical History Mysteries videos …
- Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound: What's the difference?
- Drug interactions 101: What dentists and dental hygienists should know
- 5 things that should be in every medical history
The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory.
Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.
About the Author
Pamela Maragliano, DMD
Pamela Maragliano, DMD, is the chief editor of Dental Economics. Based in Salem, Massachusetts, Dr. Maragliano began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].
Tom Viola, RPh, CCP
With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.